ICN Increases Stake in Syncor International

ICN Pharmaceuticals has boosted its stake in Syncor International Corp., a Chatsworth maker of radiopharmaceuticals, by more than 1% to 6.5%, according to a filing with the Securities and Exchange Commission.

Between May 5 and June 10, ICN bought 110,500 shares of Syncor common stock at $4.75 to $6.85 each. ICN, based in Costa Mesa, now holds 678,000 shares of Syncor common stock.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World